Planned Clinical Trial of Low Dose Selinexor in Patients with Severe COVID-19

Karyopharm Therapeutics announced plans to commence a global randomized clinical trial for low dose oral selinexor in hospitalized patients with severe COVID-19.

Source: CancerNetwork - April 13, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news